204 related articles for article (PubMed ID: 17090848)
21. Systemic bacillus Calmette-Guerin infection in patients treated by intravesical BCG therapy for superficial bladder cancer.
Steg A; Leleu C; Debré B; Boccon-Gibod L; Sicard D
Prog Clin Biol Res; 1989; 310():325-34. PubMed ID: 2672020
[TBL] [Abstract][Full Text] [Related]
22. Vitiligo--an autoimmune side-effect of intravesical bacillus Calmette-Guérin instillation?
Beisland C; Holsen DS
Scand J Urol Nephrol; 2004; 38(2):182-3. PubMed ID: 15204415
[TBL] [Abstract][Full Text] [Related]
23. Histopathology of Disseminated Mycobacterium bovis Infection Complicating Intravesical BCG Immunotherapy for Urothelial Carcinoma.
Larsen BT; Smith ML; Grys TE; Vikram HR; Colby TV
Int J Surg Pathol; 2015 May; 23(3):189-95. PubMed ID: 25614462
[TBL] [Abstract][Full Text] [Related]
24. Reiter's syndrome postintravesical Bacillus Calmette-Guérin instillations.
Ng KL; Chua CB
Asian J Surg; 2017 Apr; 40(2):163-165. PubMed ID: 25183290
[TBL] [Abstract][Full Text] [Related]
25. Granulomatous epididymo-orchitis, a rare complication of intravesical bacillus Calmette-Guérin therapy for urothelial cancer.
Harving SS; Asmussen L; Roosen JU; Hermann G
Scand J Urol Nephrol; 2009; 43(4):331-3. PubMed ID: 19396724
[TBL] [Abstract][Full Text] [Related]
26. Mycotic aneurysm of the popliteal artery as a complication of intravesical BCG therapy for superficial bladder cancer. Case report and literature review.
Witjes JA; Vriesema JL; Brinkman K; Bootsma G; Barentsz JO
Urol Int; 2003; 71(4):430-2. PubMed ID: 14646447
[TBL] [Abstract][Full Text] [Related]
27. Miliary Mycobacterium bovis induced by intravesical bacille Calmette-Guérin immunotherapy.
McParland C; Cotton DJ; Gowda KS; Hoeppner VH; Martin WT; Weckworth PF
Am Rev Respir Dis; 1992 Nov; 146(5 Pt 1):1330-3. PubMed ID: 1443892
[TBL] [Abstract][Full Text] [Related]
28. Fatal sepsis following intravesical bacillus Calmette-Guerin administration for bladder cancer.
Rawls WH; Lamm DL; Lowe BA; Crawford ED; Sarosdy MF; Montie JE; Grossman HB; Scardino PT
J Urol; 1990 Dec; 144(6):1328-30. PubMed ID: 2231917
[TBL] [Abstract][Full Text] [Related]
29. Granulomatous hepatitis caused by Bacillus Calmette-Guerin (BCG) infection after BCG bladder instillation.
Leebeek FW; Ouwendijk RJ; Kolk AH; Dees A; Meek JC; Nienhuis JE; Dingemans-Dumas AM
Gut; 1996 Apr; 38(4):616-8. PubMed ID: 8707098
[TBL] [Abstract][Full Text] [Related]
30. Systemic BCG infection in a patient with pancytopaenia and fever 9 years after intravesical BCG administration for bladder cancer.
Westhovens IM; Vanden Abeele ME; Messiaen PE; van der Hilst JCh
BMJ Case Rep; 2016 May; 2016():. PubMed ID: 27170615
[TBL] [Abstract][Full Text] [Related]
31. Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy for bladder carcinoma.
Marans HY; Bekirov HM
J Urol; 1987 Jan; 137(1):111-2. PubMed ID: 3795348
[TBL] [Abstract][Full Text] [Related]
32. Bladder contracture: review for intravesical bacillus Calmette-Guerin complication.
Hameed A; Sezian N; Thwaini A
Can J Urol; 2007 Dec; 14(6):3745-9. PubMed ID: 18163926
[TBL] [Abstract][Full Text] [Related]
33. [Surgical site infection by bacillus Calmette-Guerin (BCG) after radical cystectomy, occurring after intravesical bcg therapy: a case report].
Muranaka T; Kunishima Y; Shigyo M; Kato R; Masumori N; Ito N; Tsukamoto T; Takagi Y; Seki M; Toida I
Hinyokika Kiyo; 2007 Aug; 53(8):581-4. PubMed ID: 17874552
[TBL] [Abstract][Full Text] [Related]
34. Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guerin instillation for bladder carcinoma.
Proctor DD; Chopra S; Rubenstein SC; Jokela JA; Uhl L
Am J Gastroenterol; 1993 Jul; 88(7):1112-5. PubMed ID: 8317415
[TBL] [Abstract][Full Text] [Related]
35. Ocular involvement following Bacillus Calmette-Guerin immunotherapy for bladder carcinoma.
Cugati S; Gilhotra JS; Lake S; Gordon DL
Clin Exp Ophthalmol; 2014 Jul; 42(5):494-5. PubMed ID: 24372891
[No Abstract] [Full Text] [Related]
36. [Prophylactic effect of inductive intravesical instillation of Bacillus Calmette-Guerin on postoperative recurrence of bladder cancer].
Yi SH; Ye G; Wang XW; Jin HS; Zhang YN; Yan ZL
Ai Zheng; 2008 Nov; 27(11):1208-11. PubMed ID: 19000455
[TBL] [Abstract][Full Text] [Related]
37. Peritoneal tuberculosis and granulomatous hepatitis secondary to treatment of bladder cancer with Bacillus Calmette-Guérin.
Soylu A; Ince AT; Polat H; Yasar N; Ciltas A; Ozkara S; Tasci AI
Ann Clin Microbiol Antimicrob; 2009 Apr; 8():12. PubMed ID: 19368735
[TBL] [Abstract][Full Text] [Related]
38. Fatal disseminated mycobacterial infection following intravesical bacillus Calmette-Guerin.
Deresiewicz RL; Stone RM; Aster JC
J Urol; 1990 Dec; 144(6):1331-3; discussion 1333-4. PubMed ID: 2231918
[TBL] [Abstract][Full Text] [Related]
39. Disseminated Bacillus Calmette-Guérin (BCG) infection and acute exacerbation of interstitial pneumonitis: an autopsy case report and literature review.
Shimizu G; Amano R; Nakamura I; Wada A; Kitagawa M; Toru S
BMC Infect Dis; 2020 Sep; 20(1):708. PubMed ID: 32993546
[TBL] [Abstract][Full Text] [Related]
40. Bacillus Calmette-Guérin failure in patients with non-muscle-invasive urothelial carcinoma of the bladder may be due to the urologist's failure to detect urothelial carcinoma of the upper urinary tract and urethra.
Giannarini G; Birkhäuser FD; Recker F; Thalmann GN; Studer UE
Eur Urol; 2014 Apr; 65(4):825-31. PubMed ID: 24144432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
